Parkinson's Disease
Those suffering from Parkinson's Disease often have non-motor psychiatric symptoms. Through the Neuromodulation Therapy options offered by the Istituto di Neuroscienze, we are able to act effectively and in a specialized manner on both motor and non-motor symptoms.
Find out more about our treatment plan!
Novel therapies for Parkinson's disease
Non-invasive Neuromodulation Therapies, including Transcranial Magnetic Stimulation (TMS), Transcranial Continuous Direct Current Stimulation (tDCS), and Photo-Bio-Modulation (PBM), are gaining increasing application among patients with neurological and psychiatric disorders.
These innovative techniques offer an advanced and promising therapeutic approach for a wide range of conditions, including Parkinson's disease. A growing number of scientific publications increasingly affirm the effectiveness of these therapies in improving the quality of life of patients with this neurodegenerative disease.
Particularly, Transcranial Magnetic Stimulation (TMS) has been shown to be highly effective in treating symptoms related to Parkinson's disease. This non-invasive technique allows modulation of brain activity in regions involved in the disease, helping to improve patients' mobility, stability, and quality of movement. It is also shown to be highly effective in the management of non-motor symptoms of Parkinson's, thus representing a method of intervention with high therapeutic potential.
Neuromodulation Therapies represent an innovative and promising therapeutic perspective for patients with Parkinson's symptoms, offering a non-pharmacological and non-invasive treatment option that can significantly improve their quality of life. The increasing scientific evidence basis supporting their application offers a new perspective of hope in the management of Parkinson's disease, offering the possibility of tangible improvements on many different areas of the disorder.
Parkinson's Treatment Program
A Comprehensive Approach with Neuromodulation Therapies
The Istituto di Neuroscienze's Parkinson's Treatment Program is designed to offer a comprehensive and targeted intervention approach to patients with this complex disease, making use of the most innovative Neuromodulation Therapies with the aim of providing the greatest possible support to those living with Parkinson's.
① NEUROPSYCHOLOGICAL EVALUATION
Our program starts with a detailed neuropsychological assessment, which helps our Team of professionals understand the specific needs of each patient.
② ASSESSMENT OF ADDICTIONS
The neuropsychological evaluation is complemented by additional assessments to identify the presence of any addictions in patients undergoing treatment for Parkinson's disease, thus ensuring comprehensive support for the patient's overall well-being.
③ BEHAVIORAL ASSESSMENT
Within our program we place special emphasis on the analysis of all elements that might influence treatment choice. For this reason, a full assessment of the clinical picture must also include the investigation of possible extra-motor and sleep behavioral disorders. This is a key element of our approach to diagnosis so that we are able to provide patients with individualized and targeted treatment.
④ COGNITIVE REHABILITATION
Cognitive rehabilitation is an essential component of our program, helping to improve cognitive functions that may be impaired and to preserve the patient's quality of life.
⑤ NEUROMODULATION THERAPIES
Neuromodulation Therapies ― including Transcranial Magnetic Stimulation (TMS), Transcranial Continuous Electrical Stimulation (tDCS), and Photo-Bio-Modulation (PBM) ― are integrated into the intervention program to modulate brain activity in a targeted way, improving motor and non-motor symptoms of Parkinson's. They can be implemented in a highly personalized manner, making it possible to "tailor" a specialized intervention program to the single needs of the individual patient.
⑥ PSYCHOLOGICAL SUPPORT
Finally, the treatment program includes psychological support interventions addressed not only to the patient himself, but also to his family members and caregivers, recognizing the importance of a comprehensive approach in the management of Parkinson's disease.
